WOCKPHARMA — Wockhardt Share News
0.000.00%
Last trade - 00:00- IN₹317.66bn
- IN₹337.11bn
- IN₹33.73bn
India's Senores Pharma up on buying generic hypertension drug from Wockhardt
India's Wockhardt rises on antibiotic drug's clinical study results
Brief: Wockhardt Says Zaynich Achieves Over 97% Efficacy In Clinical Study
India's Wockhardt scales 9-year peak on antibiotic drug approval
Brief: Wockhardt Says Indian Drug Regulator Approves Wockhardt's Antibiotic Miqnaf
India's Wockhardt jumps after drug aids liver transplant in US cancer patient
Brief: Wockhardt Says Zaynich Enables Successful Liver Transplant For US Cancer Patient
India's Wockhardt gains as Q2 loss narrows
Brief: Wockhardt Sept-Quarter Consol Net Loss 220 Million Rupees
India's Wockhardt gains on block deals at premium
Brief: Wockhardt Files Fast-Acting Insulin Aspart Injection With DCGI
India's Wockhardt gains after seeking regulatory nod for fast-acting insulin injection
Brief: Wockhardt Ltd Says Nafithromycin Gets Favourable Recommendation From CDSCO
Brief: Wockhardt Says Wck 6777 Granted Fast Track Designation By Us FDA, Completes Phase I Study
India's Wockhardt up after drug found effective in meningitis case
Brief: Wockhardt Says Co's Investigational Drug, Zaynich Cures Complex Case Of Meningitis
India market regulator chief says she complied with all required disclosures (updated)
Brief: Wockhardt Denies Allegations Pertaining To Payment Of Rent By Carol Info Services
India's Wockhardt climbs on narrower Q1 loss